1 |
Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017[J]. Lancet, 2020,395(10225):709-733.
|
2 |
Floege J, Amann K. Primary glomerulonephritides[J]. Lancet, 2016,387(10032):2036-2048.
|
3 |
常伟, 孙汉英, 曾红兵,等. 火把花根对系膜增殖性肾炎大鼠TGF-β1和Smad3表达的影响[J]. 中国血液流变学杂志,2007,17(3):364-366,407.
|
4 |
常伟, 孙汉英, 曾红兵,等. 火把花根对系膜增殖性肾炎模型大鼠单核细胞趋化因子-1与转化生长因子β1表达的影响[J]. 医药导报,2008,27(5):505-508.
|
5 |
胡娟, 杨武斌, 米本中,等. 火把花根片对Lewis大鼠佐剂性关节炎影响及机制研究[J]. 中药药理与临床,2017,33(5):82-87.
|
6 |
王丽娟, 余江毅, 罗玫,等. 火把花根片干预临床期糖尿病肾病的近期疗效及对血清 HGF 水平的影响[J]. 南京中医药大学学报,2015(5):424-427.
|
7 |
钟秋生, 周光辉, 朱永坤,等. 补肾活血方合火把花根片对类风湿关节炎血清免疫球蛋白的影响[J]. 光明中医,2008,23(10):1501-1502.
|
8 |
Moldoveanu Z, Suzuki H, Reily C, et al. Experimental evidence of pathogenic role of IgG autoantibodies in IgA nephropathy[J]. J Autoimmun, 2021,118:102593.
|
9 |
Schmidt T, Luebbe J, Kilian C, et al. IL-17 receptor c signaling controls CD4(+) T(H)17 immune responses and tissue injury in immune-mediated kidney diseases[J]. J Am Soc Nephrol, 2021,32(12):3081-3098.
|
10 |
|
11 |
|
12 |
Booij TH, Leonhard WN, Bange H, et al. In vitro 3D phenotypic drug screen identifies celastrol as an effective in vivo inhibitor of polycystic kidney disease[J]. J Mol Cell Biol, 2020,12(8):644-653.
|
13 |
Zhao P, Wang H, Jin DQ, et al. Terpenoids from Tripterygium hypoglaucum and their inhibition of LPS-induced NO production[J]. Biosci Biotechnol Biochem, 2014,78(3):370-373.
|
14 |
Zhong J, Xian D, Xu Y, et al. Efficacy of Tripterygium hypoglaucum Hutch in adults with chronic urticaria[J]. J Altern Complement Med, 2011,17(5):459-464.
|
15 |
谢晓东, 李小生. 中西医结合治疗慢性肾小球肾炎临床观察[J]. 中国中医药现代远程教育,2021,19(23):127-129.
|
16 |
申小荣. 中医药治疗原发性肾小球性血尿26例分析[J]. 实用中医内科杂志,2006,20(5):533.
|
17 |
楼妍, 袁军, 付彤飞,等. 具有免疫抑制的中成药联合西药治疗膜性肾病的网状Meta分析[J]. 世界中医药,2023,18(3):346-354.
|
18 |
孙建军. 火把花根片治疗肾病综合征继发脂质代谢紊乱临床观察[J]. 中国社区医师(医学专业半月刊),2008(22):123.
|